RJR-2429

RJR-2429.svg

RJR-2429' is a chemical compound that acts as a nicotinic acetylcholine receptor (nAChR) agonist. It is primarily used in scientific research to study the effects of nAChR activation.

Chemical Structure and Properties

RJR-2429 is a synthetic compound with a complex chemical structure. It is classified as a nicotine analog due to its ability to bind to and activate nicotinic acetylcholine receptors. The molecular formula of RJR-2429 is C 10H 14N 2, and it has a molecular weight of 162.23 g/mol.

Mechanism of Action

RJR-2429 functions by binding to the nicotinic acetylcholine receptors, which are a type of ligand-gated ion channel found in the central nervous system and peripheral nervous system. Upon binding, it mimics the action of the neurotransmitter acetylcholine, leading to the opening of the ion channel and subsequent influx of sodium ions. This results in the depolarization of the neuron and the propagation of an action potential.

Research Applications

RJR-2429 is used extensively in neuroscience research to investigate the role of nicotinic acetylcholine receptors in various physiological and pathological processes. It has been studied in the context of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, as well as in addiction research to understand the mechanisms underlying nicotine addiction.

Pharmacological Effects

The activation of nicotinic acetylcholine receptors by RJR-2429 can lead to a variety of pharmacological effects, including enhanced cognitive function, increased alertness, and improved memory. These effects are similar to those observed with nicotine, but RJR-2429 is often preferred in research due to its specificity and potency.

Safety and Toxicity

As with many research chemicals, the safety and toxicity profile of RJR-2429 is not fully understood. It is typically handled with caution in laboratory settings, and its use is restricted to controlled environments.

See Also

• Nicotinic acetylcholine receptor
• Nicotine
• Acetylcholine
• Neurotransmitter
• Ligand-gated ion channel
• Neurodegenerative disease
• Addiction

References

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian